ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
SILICON VALLEY, CA - July 10, 2025 ( NEWMEDIAWIRE ) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ('Company'), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, today announced that it has received a $150,000 cash licensing payment from AiBtl BioPharma Inc., one of its key strategic partners, as part of a broader licensing agreement signed earlier this year.
The payment marks a significant milestone in the continuing commercialization of ABVC's late-stage drug candidates ABV-1504 and ABV-1505, which are being developed for Major Depressive Disorder (MDD) and Attention Deficit Hyperactivity Disorder (ADHD) respectively. Both candidates have completed Phase II and Phase IIB clinical trials and hold active INDs with the U.S. Food and Drug Administration.
'This milestone payment reflects the accelerating momentum behind our global licensing strategy and validates the value of our late-stage clinical assets,' said Dr. Uttam Patil, ABVC Chief Executive Officer. 'Our partnership with AiBtl exemplifies how we are strategically collaborating with innovation-focused companies to bring our botanical therapies to market worldwide.'
Cumulative Licensing Milestone
To date, AiBtl BioPharma has paid a total of $350,000 in cash milestone licensing fees to ABVC. Including earlier payments from other strategic partners such as ForSeeCon and OncoX, ABVC has received a cumulative total of $846,000 in non-dilutive licensing income. These milestone payments reflect growing interest in ABVC's late-stage botanical drug portfolio and reinforce the Company's capital-efficient, partnership-driven business model.
Strengthening a Global Platform for Botanical Innovation
Over the past six months, ABVC has successfully executed licensing agreements with multiple partners across North America and Asia, including:
AiBtl BioPharma Inc. - Licensed ABV-1504 and ABV-1505 for global development and commercialization, for which ABVC will receive equity, cash milestone payments, and royalties. ABVC and its subsidiary BioLite Inc. received 46M AiBtl shares, and are eligible for potential $7M cash payment, and royalties up to $200M after the product launches.
ForSeeCon Eye Corporation - Secured a license for ophthalmic indications under ABVC's botanical IP platform. ABVC and its subsidiaries BioFirst Corporation have received 10M ForSeeCon shares, and are eligible for potential $7M cash payment, and royalties up to $120M after the product launches.
OncoX BioPharma, Inc. - Entered into a deal to expand botanical innovation into the oncology space. ABVC and its subsidiaries BioLite Inc. and Rgene Corporation are received up to 10M OncoX shares, and are eligible for potential $5M cash payment, and royalties up to $50M after the product launches.
These deals are aligned with ABVC's asset-light business model, focusing on developing innovative botanical drugs through Phase II/III, and licensing out clinical-stage products to commercial partners for global expansion.
Outlook and Commitment to Shareholder Value
This $150,000 payment is part of a larger milestone and royalty structure that is expected to contribute significantly to ABVC's 2025 revenue stream. The company previously announced a 234% increase in annual revenue and a 77% year-over-year improvement in earnings per share, reflecting its capital-efficient approach and licensing-driven growth. These improvements reflect ABVC's pivot toward a licensing-first strategy, which is designed to generate recurring milestone income and reduce the need for dilutive fundraising.
'Our licensing-first strategy is working, and today's payment is one of several anticipated milestone payments as partners progress clinical development activities under our licensing agreements,' added Dr. Patil. 'We remain committed to creating sustainable long-term value for our shareholders through focused innovation, smart partnerships, and disciplined execution.'
Addressing a Global Need for CNS Therapies
The growing demand for alternative and effective treatments for CNS disorders has become more urgent globally. According to The Daily Telegraph (July 7, 2025), Australia is currently facing a serious drug shortage, with nearly 300,000 patients expected to be affected, potentially driving some to seek medication through illegal channels. ABVC and AiBtl's progress in botanical drug development could offer a timely and legal therapeutic alternative to vulnerable patient populations in need. [1]
[1]https://ttmgoal.com/news/2549374126?edition=fundamental&utm_source=news&utm_campaign=2549374126&utm_medium=telegram&platform=iOS&shareID=fd3ffdab45abd814bfccde5ecba5541b&invite=P2VN3E⟨=en_US
About AiBtl BioPharma Inc.
AiBtl BioPharma Inc. is a Delaware-based biopharmaceutical company focused on the development of botanical-based therapeutic candidates for central nervous system (CNS) disorders, including major depressive disorder (MDD) and attention deficit hyperactivity disorder (ADHD). Leveraging a combination of traditional botanical knowledge and modern clinical research, AiBtl seeks to advance drug candidates derived from Polygala tenuifolia, a traditional medicinal herb. AiBtl operates with a strategic focus on Asia-Pacific markets and is exploring collaborative opportunities with global pharmaceutical partners to support late-stage development and commercialization. ABVC BioPharma currently holds a majority ownership stake in AiBtl.
About ABVC BioPharma & Its Industry
ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus(R)) under development. For its drug products, the Company utilizes in-licensed technology from its network of world-renowned research institutions to conduct proof-of-concept trials through Phase II of clinical development. The Company's network of research institutions includes Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center. For Vitargus(R), the Company intends to conduct pivotal clinical trials (Phase III) through global partnerships.
Forward-Looking Statements
This press release contains 'forward-looking statements.' Such statements may be preceded by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential,' or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. None of the outcomes expressed herein are guaranteed. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our product candidates on a commercial scale on our own, or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to proceed to the next level of the clinical trials or to market our product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
This press release does not constitute an offer to sell, or the solicitation of an offer to buy any of the Company's securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company's securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
Contact:
Uttam Patil
Email: [email protected]
View the original release on www.newmediawire.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Udemy Launches AI-Powered Platform in Arabic, Fueling Skills Acceleration Across the Middle East
New expansion aims to empower over 300 million Arabic-speaking professionals with personalized, adaptive upskilling SAN FRANCISCO, August 14, 2025--(BUSINESS WIRE)--Udemy (Nasdaq: UDMY), a leading AI-powered skills acceleration platform, announced the recent launch of its platform in Arabic. This milestone reflects the global technology company's continued expansion across the Middle East, reinforcing Udemy's mission to empower learners and organizations worldwide with the skills they need to stay ahead in the age of AI. Spoken by more than 300 million people in various dialects, Arabic is one of the world's most widely used languages. The newly localized Udemy platform offers an enhanced user experience in Arabic, enabling organizations and professionals across the Middle East and North Africa region to upskill and reskill in high-growth, emerging roles. In the past year, over one million learners have enrolled in more than 7,000 Arabic-language courses from Udemy's Multi-Language Collection, covering a diverse range of topics from AI and cloud computing to communication and leadership. "At Udemy, we believe language should never be a barrier to professional growth," said Hugo Sarrazin, President and CEO of Udemy. "Localizing our platform in Arabic strengthens our ability to serve our growing customer base across the region with culturally relevant, high-quality reskilling experiences. With this launch, we're helping unlock new opportunities for workforce development, product innovation, and business growth throughout the Arabic-speaking world." "With Udemy's platform now available in Arabic, professionals in the region can seamlessly access high-quality, locally relevant learning experiences," said Dr. Ryan Ahmed, Udemy instructor, CEO of Stemplicity, and Assistant Professor at McMaster University. "This advancement not only removes language barriers but also empowers Arabic-speaking professionals and leaders to build critical skills with greater confidence, speed, and cultural resonance." Dr. Ahmed's course, Artificial Intelligence from Beginner to Professional, is available in Arabic to enterprise customers and learners on the Udemy platform. To access the Udemy platform in Arabic, visit About Udemy Udemy (Nasdaq: UDMY) is an AI-powered skills acceleration platform transforming how companies and individuals across the world build the capabilities needed to thrive in a rapidly evolving workplace. By combining on-demand, multi-language content with real-time innovation, Udemy delivers personalized experiences that empower organizations to scale workforce development and help individuals build the technical, business, and soft skills most relevant to their careers. Today, thousands of companies, including Ericsson, Samsung SDS America, On24, Tata Consultancy Services, The World Bank, and Volkswagen, rely on Udemy Business for its enterprise solutions to build agile, future-ready teams. Udemy is headquartered in San Francisco, with hubs across the United States, Australia, India, Ireland, Mexico, and Türkiye. View source version on Contacts Media Contact Risha TyagiSenior Global Corporate Communications Managerpress@
Business Wire
30 minutes ago
- Business Wire
Udemy Launches AI-Powered Platform in Arabic, Fueling Skills Acceleration Across the Middle East
SAN FRANCISCO--(BUSINESS WIRE)-- Udemy (Nasdaq: UDMY), a leading AI-powered skills acceleration platform, announced the recent launch of its platform in Arabic. This milestone reflects the global technology company's continued expansion across the Middle East, reinforcing Udemy's mission to empower learners and organizations worldwide with the skills they need to stay ahead in the age of AI. Spoken by more than 300 million people in various dialects, Arabic is one of the world's most widely used languages. The newly localized Udemy platform offers an enhanced user experience in Arabic, enabling organizations and professionals across the Middle East and North Africa region to upskill and reskill in high-growth, emerging roles. In the past year, over one million learners have enrolled in more than 7,000 Arabic-language courses from Udemy's Multi-Language Collection, covering a diverse range of topics from AI and cloud computing to communication and leadership. 'At Udemy, we believe language should never be a barrier to professional growth,' said Hugo Sarrazin, President and CEO of Udemy. 'Localizing our platform in Arabic strengthens our ability to serve our growing customer base across the region with culturally relevant, high-quality reskilling experiences. With this launch, we're helping unlock new opportunities for workforce development, product innovation, and business growth throughout the Arabic-speaking world.' 'With Udemy's platform now available in Arabic, professionals in the region can seamlessly access high-quality, locally relevant learning experiences," said Dr. Ryan Ahmed, Udemy instructor, CEO of Stemplicity, and Assistant Professor at McMaster University. "This advancement not only removes language barriers but also empowers Arabic-speaking professionals and leaders to build critical skills with greater confidence, speed, and cultural resonance.' Dr. Ahmed's course, Artificial Intelligence from Beginner to Professional, is available in Arabic to enterprise customers and learners on the Udemy platform. To access the Udemy platform in Arabic, visit About Udemy Udemy (Nasdaq: UDMY) is an AI-powered skills acceleration platform transforming how companies and individuals across the world build the capabilities needed to thrive in a rapidly evolving workplace. By combining on-demand, multi-language content with real-time innovation, Udemy delivers personalized experiences that empower organizations to scale workforce development and help individuals build the technical, business, and soft skills most relevant to their careers. Today, thousands of companies, including Ericsson, Samsung SDS America, On24, Tata Consultancy Services, The World Bank, and Volkswagen, rely on Udemy Business for its enterprise solutions to build agile, future-ready teams. Udemy is headquartered in San Francisco, with hubs across the United States, Australia, India, Ireland, Mexico, and Türkiye.
Yahoo
an hour ago
- Yahoo
Intuitive Machines Announces Upsize and Pricing of Private Offering of $300 Million of Convertible Senior Notes Due 2030
HOUSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) ('Intuitive Machines' or the 'Company'), a leading space exploration, infrastructure, and services company, announced today the pricing of $300.0 million aggregate principal amount of 2.500% convertible senior notes due 2030 (the 'Notes') in a private offering (the 'Notes Offering') to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the 'Securities Act'). Intuitive Machines also granted the initial purchasers of the Notes in the Notes Offering an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $45.0 million aggregate principal amount of Notes. The aggregate principal amount of the offering was increased from the previously announced offering size of $250.0 million (or $287.5 million if the initial purchasers exercise their option to purchase additional notes in full). The Notes Offering is expected to close on August 18, 2025, subject to customary closing conditions. Use of Proceeds: Intuitive Machines estimates that the net proceeds from the Notes Offering will be approximately $291.8 million (or approximately $335.5 million if the initial purchasers' option to purchase additional Notes is exercised in full), after deducting the initial purchasers' discounts and commissions, but before giving effect to estimated offering expenses payable by the Company. Intuitive Machines intends to use approximately $32.0 million of the net proceeds from the Notes Offering to pay the cost of the capped call transactions described below. Intuitive Machines intends to use the remaining net proceeds from the Notes Offering for general corporate purposes, including operations, research and development and potential acquisitions. If the initial purchasers exercise their option to purchase additional Notes, Intuitive Machines expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions with the option counterparties (as defined below), with the remainder of the net proceeds to be used for general corporate purposes, including operations, research and development and potential acquisitions. Additional Details of the Notes: The Notes will be senior, unsecured obligations of Intuitive Machines. The Notes will accrue interest at an annual rate of 2.500%, payable semiannually in arrears on April 1 and October 1 of each year, beginning on April 1, 2026. The Notes will mature on October 1, 2030, unless earlier converted, redeemed or repurchased. Prior to the close of business on the business day immediately preceding July 1, 2030, noteholders will have the right to convert their Notes only upon the satisfaction of specified conditions and during certain periods. On or after July 1, 2030, and until the close of business on the second scheduled trading day immediately preceding July 1, 2030, noteholders may convert their Notes at any time regardless of these conditions. The initial conversion rate will be 76.2631 shares of Intuitive Machines' Class A common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $13.1125 per share of Intuitive Machines' Class A common stock, which represents a premium of approximately 25.0% over the last reported sale price of $10.49 per share of Intuitive Machines' Class A common stock on the Nasdaq Global Market on August 13, 2025). The conversion rate and conversion price will be subject to adjustment upon the occurrence of certain events. In addition, upon certain corporate events or upon a notice of redemption (as described below), Intuitive Machines will, under certain circumstances, increase the conversion rate for Noteholders who convert Notes in connection with such a corporate event or notice of redemption. Intuitive Machines will settle conversions of Notes by paying or delivering, as the case may be, cash, shares of Intuitive Machines' Class A common stock, or a combination thereof, at Intuitive Machines' election. The Notes will not be redeemable at Intuitive Machines' option prior to October 6, 2028. Intuitive Machines may, at its option, redeem all or any portion of the Notes for cash on or after October 6, 2028 and prior to the 26th trading day immediately preceding the maturity date, but only if the last reported sale price per share of Intuitive Machines' Class A common stock equals or exceeds 130% of the conversion price for a specified period of time and certain liquidity and other conditions have been satisfied. The redemption price will be equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Noteholders will have the right, subject to certain conditions and exceptions described in the indenture governing the Notes (the 'indenture'), to require Intuitive Machines to repurchase for cash all or a portion of their Notes upon the occurrence of a 'fundamental change' (as defined in the indenture) at a repurchase price of 100% of their principal amount plus accrued and unpaid interest, if any, to, but excluding, the relevant repurchase date. Capped Call Transactions: In connection with the pricing of the Notes, Intuitive Machines entered into privately negotiated capped call transactions with certain financial institutions (the 'option counterparties'). The capped call transactions cover, subject to customary adjustments, the number of shares of Intuitive Machines' Class A common stock initially underlying the Notes. The capped call transactions are expected generally to reduce the potential dilution to Intuitive Machines' Class A common stock upon any conversion of Notes and/or offset any cash payments Intuitive Machines is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap. The cap price of the capped call transactions is initially $20.9800 per share, which represents a premium of 100% over the last reported sale price of Intuitive Machines' Class A common stock of $10.49 per share on the Nasdaq Global Market on August 13, 2025, and is subject to certain adjustments under the terms of the capped call transactions. Intuitive Machines has been advised that in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to enter into various derivative transactions with respect to Intuitive Machines' Class A common stock and/or purchase shares of Intuitive Machines' Class A common stock concurrently with or shortly after the pricing of the Notes. This activity could increase (or reduce the size of any decrease in) the market price of Intuitive Machines' Class A common stock or the Notes at that time. In addition, the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Intuitive Machines' Class A common stock and/or purchasing or selling Intuitive Machines' Class A common stock or other securities of Intuitive Machines in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so during the 25 trading day period beginning on the 26th scheduled trading day prior to the maturity date of the Notes, or, to the extent Intuitive Machines exercises the relevant termination election under the capped call transactions, following any repurchase, redemption or conversion of the Notes). This activity could also cause or avoid an increase or a decrease in the market price of Intuitive Machines' Class A common stock or the Notes, which could affect a noteholder's ability to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, it could affect the number of shares of Class A common stock, if any, and value of the consideration that a noteholder will receive upon conversion of its Notes. Notices The Notes are only being offered and will only be sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act in a private offering. Neither the Notes nor the shares of Intuitive Machines' Class A common stock issuable upon conversion of the Notes, if any, have been, or will be, registered under the Securities Act or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold in the United States, except pursuant to an applicable exemption from, or in a transaction not subject to, such registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the Notes or shares of Intuitive Machines' Class A common stock issuable upon conversion of the Notes in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Intuitive Machines Intuitive Machines is a diversified space technology, infrastructure, and services company focused on fundamentally disrupting lunar access economics. In 2024, Intuitive Machines successfully soft-landed the Company's Nova-C class lunar lander, on the Moon, returning the United States to the lunar surface for the first time since 1972. In 2025, Intuitive Machines returned to the lunar south pole with a second lander. The Company's products and services are focused through three pillars of space commercialization: Delivery Services, Data Transmission Services, and Infrastructure as a Service. Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words such as 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'strive,' 'would,' 'strategy,' 'outlook,' the negative of these words or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include but are not limited to statements regarding: our anticipated use of net proceeds from the Notes Offering and the satisfaction of closing conditions related to the Notes Offering. These forward-looking statements reflect the Company's predictions, projections, or expectations based upon currently available information and data. Our actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements based on a number of factors, risks, uncertainties and assumptions, including, among others, uncertainties related to the completion of the Notes Offering and capped call transactions, including risks related to the satisfaction of the closing conditions for the sale of the Notes, and other risks described in the Company's other public filings and press releases other factors detailed under the section titled Part I, Item 1A. 'Risk Factors' of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC, the section titled Part I, Item 2. 'Management's Discussion and Analysis of Financial Condition and Results of Operations' and the section titled Part II. Item 1A. 'Risk Factors' in our most recently filed Quarterly Report on Form 10-Q, our Current Reports on Form 8-K and in our subsequent filings with the SEC, which are accessible on the SEC's website at and the Investors section of our website at These forward-looking statements are based on information available as of the date of this press release and current expectations, forecasts, and assumptions, and involve a number of judgments, risks, and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. Contacts For investor inquiries:investors@ For media inquiries:press@ This press release was published by a CLEAR® Verified individual.
